michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Thanks, Gary. It is Bruce. I think the way to think about it is maintaining the 20% EBITDA level overall. We might move the money back and forth a little bit over time, programmatically and also through the shifting of where the people cost is between sales and marketing and product. But on the whole, we're really very focused on maintaining that 20% EBITDA level.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Just thinking about your comments on pricing expectations later in the year. Thinking out COVID, how are you thinking about the durability of pricing in the base business ex the COVID testing that we're seeing right now?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Tom. First of all, I have -- Yeah, we're not getting reports, maybe it might be your connection. I know last quarter we had some issues and people were telling that right away, but we are not getting those reports. So, I just want to be FII. And if other people aren't, please ping or chat to the operator. We actually specifically picked the new room to make sure we wouldn't have that this time. So, as it relates to patients currently on NEXLIZET and NEXLETOL, I think we see a good mix of patients who are on statins and who are on statins and ezetimibe, that are taking both of these products. So, our positioning, of course, right now as we've mentioned is talking about those patients who are on a statin plus ezetimibe. And then before you would actually go to an injectable PCSK9, we think there's the room and ability to use NEXLIZET and NEXLETOL. There are other doctors who are -- just use statins and they have added NEXLETOL or NEXLIZET. So, -- and right now, the split of those two drugs, when you look at NEXLETOL and NEXLIZET, is approximately 50-50 in the use of both of those drugs.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. I think in terms of China, in particular, we still see that general engineering is on an uptick there. They were, obviously, also affected by shortages from transportation. But, in fact, from Q3 to Q1, we saw a decline. We think that's going to kind of level out here Q4 to Q1. But then transportation should be back on track there. So China for us is -- well, it may have kind of slowed a little bit here because of the transportation disruption, it's still on an upward trajectory in general. And remember, their growth rate may slow over time and maybe a little bit -- maybe slowing relative to other markets but they are also further along in terms of the recovery. They started earlier. But we still think that it's going to be very positive for us going forward this year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good afternoon. Thanks for taking the question and congrats on the nice quarter. Mike, I am glad to hear you talk about the trend you are seeing in your mitral and tricuspid businesses. The $80 million to $100 million guidance for this year, what percent is mitral? What percent is tricuspid? And how significant clinical sales in that TMTT number?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So Steve, I think that's a great question, and I think it really ties into a lot of what we talked about in the last earnings call. We definitely saw from the in-park spend perspective and an improvement in trend as we went through as we got more stuffed. And that's why we talked about the fact that we were making these investments in wage rates to get the quality of labor that we needed to deliver the in-park services that our guests were expecting. And sure enough, you saw that in our per caps, our per caps actually accelerated versus Q2. And we're really pleased to see what we did.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Matthew.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Reflecting back on Adam's question, we do see inflation coming off a bit in pulp, really in the fourth quarter. and this is more accounting fund in terms of when you actually buy the pulp to when you actually sell it, there's probably at least a quarter that we have flowing through our P&L.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I respect that.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Kirk. Next question, please.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, yeah, yeah. It's important to mention half of what we produce, we sell in LatAm, right, and half we export to other places. So every time we have this excess demand, we actually reduce what we sell to outside LatAm.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. I would say at the beginning of the pandemic, we did have to resource a few hundred fabricated metal components out of Asia back to the US for continuity of supply chain. But that was completed a couple or three quarters ago. I would say right now our supply chain is holding up pretty well. And it's not really a constraint right now. We are obviously on top of it very aggressively, but we are able to manage through the supply chain issues.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure, Julien. As you can probably imagine, we are talking to rating agencies all the time. We are talking to them about our operational risk mitigation as well as just what's going on more generally in California, and providing them with updates as we have with all of you on where the settlements landed back last year and all of that. So we've been having those sorts of conversations. As we've mentioned before, we think that the equity plan that we have in place or the financing plan that we have in -- have had in place and announced last year is very supportive of the FFO-to-debt range that we're targeting and supportive of investment-grade ratings. I'm sure you've read all the recent reports that the agencies have put out. The metrics on a look back basis are skinny, but that's why the plan to issue equity and to move forward with that so that we can support the balance sheet appropriately.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
What we've said over the years is that certainly, we look at our gross profit as a combination of a gross margin plus a membership fee. But we really don't look at it together in that way that, hey, if we do something with a membership fee, we could be more aggressive on pricing. I remember years ago, somebody had asked when the economy had softened and our comps had weakened a little bit, and we're coming up on kind of that fifth anniversary-ish of a pending increase and somebody said, given the economy is weaker, you -- and your sales have weakened a little bit, still a positive number, but weakened a little bit, would you still do it? And the response at the time was more likely we're going to do it because that's what we do. We could drive lower prices with it and drive more business.
And so we really do -- we look at the loyalty. And certainly, the loyalty and renewal rates have been up--

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, how's it going? You mentioned pent-up demand a few times in the release. Just any color you can provide on spring pass sale trends in April or May that may not be reflected in that 1.8 million number? And then, kind of how are you handling the spring pass selling period with those parks closed? And I have another, if I may.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
The seasonality of performance. I think, I mean the seasonality in our earnings in the year is what is always has been. So we don't see any changes there and of course, certain events like we have to live through here may affect the specific quarter, but seasonality is the same.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. As I just mentioned, we have optimized the significant amount of the excess liquidity over the last year, including the June payoff of $100 million senior debt and the doubling up the investment portfolio over the last year. We would look to continue to do that and we're doing it with an eye toward the BMT transaction, and the post combination balance sheet optimization. So we do see the opportunity to continue to increase the size of the investment portfolio that works within our framework of acceptable investments, the low-risk moderate yield and providing the cash flow liquidity that we expect from the portfolio. So you'd likely see that continue to increase in the second half of the year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, good morning. Congratulations on the quarter. Thanks for taking my questions. I want to go back a little bit to your strategy here, Zach, your team, with acquisitions taking a stake in companies now.
Not to mention the Inner Spirit Holdings acquisition specifically, but can you maybe help us understand -- I mean, what is the overarching strategy here? We note that, you know, you are in the process of acquiring Inner Spirit versus, you know, taking a stake in other companies. I think you mentioned on the -- on your prepared remarks, balanced company. There's also Indiva. So what is the overarching strategy here? Is it a combination of both? Or are there certain metrics you're looking for in certain companies to decide how to proceed? Or just any commentary on the strategy there would be helpful.
Thanks.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Can you say it again?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, great question, Kyle. We pride ourselves on moving fast. And so having a first move or status and advantage is something that we're really eager and excited about. But at the same time, we also know that we are creating and building a market.
And so, we not only take great pride in that, but we also appreciate that we've got to do it the right way. So for us, the right way is utilizing data. It's not just pushing tests out, let's push test out with data. And so, we fully expect that there will be competitive threats that will come our way, but knowing that we've got a two-plus and maybe even a three-year head start an advantage, when those companies and technologies are presenting validation data, we're gonna be showing two and three-year-plus real-world performance.
And what we've seen with the ORACLE data that we just recently shared at CHEST is not only -- is the test in a real-world environment performing exactly as the validation that it would with PANOPTIC, but we're starting to see broader utility and more of an impact. And so, the ability to measure that we've reduced invasive procedures on benign nodules by 67%, we think that sets the bar pretty high. And so, for us, we're not gonna just stand there and say, hey, we want to compete head-to-head. We want the data to speak for itself.
We want physicians to choose based upon the test that performs best and enables them to make the right decisions for each and every patient.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I think in the first half, we should see relative stability in that core net interest margin rate, so without the PPP. After that we could -- as we we've run out of liability repricing that help us, that will be more left to just kind of the loan pricing versus how that's coming off versus the new. So we could see some pressure on NIM on the back half of the year coming from the asset side.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So the education government portion of our business is approximately 15% of our revenue with two-thirds of that being in education, the other third being in government. Government was certainly a headwind for us, really reflecting the strong COVID-related revenues we enjoyed in the prior year period for things like PPE and diagnostic testing that didn't repeat in this particular quarter. On the education front, while there's certainly some level of COVID headwind on a year-over-year basis in the quarter reflected there, we do see continued improvement in lab utilizations. And at the university level contributing to what I characterize as kind of low single-digit growth for that part of the platform. And then in the science education portion of our business, which is roughly 2% of that overall education and government platform, continues to be a bit sluggish. We haven't really seen much of a pickup this year in line with what we normally expect for curriculum deployment at K-12 districts across the United States. So the next opportunity is probably there for that recovery will be going into next year. But we're, I think, pleased with how things are developing in education portion of that business. And the government portions, they're running in some pretty tough comps just given the role that governments around the world played in deploying COVID-related offerings in prior year periods.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I think that's the way to think about it, Rick. If you look at our guidance for the year, even at 66% for the full year, we had some compressed gross margins in the first half, especially Q2 where we had a high-record installations under contract of our equipment and that put pressure on our margins in the second quarter. But if you look at our guidance for the full year, it implies that our 66.5% gross margin in the third quarter, we're going to be somewhere in line with that for the fourth quarter.
It's not going to be significant -- it shouldn't be significantly off that number based on our guidance. So in fact, it implies about 66.5% for the fourth quarter. So I think that's how you should think about it. We continue to have some -- the COVID-related headwinds that we've experienced over the last 18 months with -- as you know, with some of the higher freight costs and those types of things that are already incorporated into our guidance for this year.
So we're already thinking those through. And that's why, you know, we're guiding to 66% for this year. So --

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I can take that one. We haven't really set a firm date on it, but we imagine it will be consistent with many others, the first half of next year, we'll start to talk more quantitatively about that.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. Good morning, everyone. I guess when looking at the balance sheet, it looks like you're in a good spot right now, especially with the Albertsons look-through. So I'm just wondering why you elected to do a joint venture on the Jamestown portfolio when there's so much upside in the assets?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning, John and team, and thanks for squeezing me in maybe before Bob's third one. So, I have a quick -- quick question for you. Looking at Slide 12 just on the operating cash margins, John, I mean, obviously, you continue to have great margins on North Sea, among -- among the, you know, the others. I'm just wondering, given the type of margins you continue to see there, you know, why not push that even -- even further?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey. Thanks so much. Good morning to all of you, guys. I'll also follow up on Ramsey's question and, Alex, I totally hear your frustration on valuation.
And I know you've been with some private equity investors in the past before but just to put you on the spot, why not go private then if there is frustration on value? Any reason not to from a business or a cultural perspective at this point of the recovery, if you don't mind me, putting you on a spot there to ask you that?

    Prediction (one of UP, DOWN, SAME): DOWN